Annexon, Inc. (ANNX) Insider Trading
Over the last 3 months, ANNX insiders made 3 open-market buys and 0 sales, a net purchase of $3.4M (SEC Form 4). Over the last 6 months, 161 institutions increased and 81 reduced their position (13F).
Insider Activity
Sentiment
100/100
Buys (3m)
3
Sells (3m)
0
Net (3m)
$3.4M
Insiders buying
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price +3.1%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 15, 2026 | JONES WILLIAM A JRdirector | Grant | 65,000 | $4.70 |
| Jun 15, 2026 | Cockroft Bettina M.director | Grant | 65,000 | $4.70 |
| Jun 15, 2026 | Choi Jungdirector | Grant | 65,000 | $4.70 |
| Jun 15, 2026 | Carson William H.director | Grant | 65,000 | $4.70 |
| Jun 15, 2026 | Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICER | Option | 30,646 | $1.85 |
| Jun 15, 2026 | Waddill William D.director | Grant | 65,000 | $4.70 |
| Jun 15, 2026 | Satter Muneer Adirector | Grant | 65,000 | $4.70 |
| May 29, 2026 | Satter Muneer Adirector | Buy | 613,497 | $5.41 |
| May 13, 2026 | Carson William H.director | Buy | 8,000 | $5.78 |
| Apr 14, 2026 | Carson William H.director | Buy | 8,000 | $6.20 |
| Mar 12, 2026 | Carson William H.director | Buy | 8,000 | $5.67 |
| Mar 4, 2026 | Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICER | Sell | 5,566 | $5.42 |
| Mar 4, 2026 | Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICER | Sell | 4,339 | $5.42 |
| Mar 4, 2026 | ARTIS DEAN RICHARDofficer: EVP & CHIEF SCIENTIFIC OFFICER | Sell | 5,894 | $5.43 |
| Mar 4, 2026 | Lew Jenniferofficer: EVP & CHIEF FINANCIAL OFFICER | Sell | 5,565 | $5.42 |
| Mar 4, 2026 | Dananberg Jamieofficer: CHIEF MEDICAL OFFICER | Sell | 5,820 | $5.43 |
| Feb 23, 2026 | Love Douglasdirector, officer: PRESIDENT AND CEO | Grant | 1,250,000 | $5.10 |
| Feb 23, 2026 | Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICER | Grant | 250,000 | $5.10 |
| Feb 23, 2026 | ARTIS DEAN RICHARDofficer: EVP & CHIEF SCIENTIFIC OFFICER | Grant | 62,500 | — |
| Feb 23, 2026 | Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICER | Grant | 62,500 | — |
| Feb 23, 2026 | Dananberg Jamieofficer: CHIEF MEDICAL OFFICER | Grant | 225,000 | $5.10 |
| Feb 23, 2026 | Dananberg Jamieofficer: CHIEF MEDICAL OFFICER | Grant | 56,250 | — |
| Feb 23, 2026 | ARTIS DEAN RICHARDofficer: EVP & CHIEF SCIENTIFIC OFFICER | Grant | 250,000 | $5.10 |
| Feb 23, 2026 | Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICER | Grant | 62,500 | — |
| Feb 23, 2026 | Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICER | Grant | 250,000 | $5.10 |
| Feb 23, 2026 | Lew Jenniferofficer: EVP & CHIEF FINANCIAL OFFICER | Grant | 62,500 | — |
| Feb 23, 2026 | Lew Jenniferofficer: EVP & CHIEF FINANCIAL OFFICER | Grant | 250,000 | $5.10 |
| Feb 20, 2026 | Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICER | Sell | 6,225 | $5.10 |
| Feb 20, 2026 | Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICER | Sell | 7,857 | $5.11 |
| Feb 20, 2026 | ARTIS DEAN RICHARDofficer: EVP & CHIEF SCIENTIFIC OFFICER | Sell | 5,290 | $5.10 |
Source: ANNX SEC Form 4 filings, latest Jun 15, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ANNX positions over the last 6 months (SEC Form 13F).
Increased
161
New positions
104
Reduced
81
Sold out
34
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| REDMILE GROUP, LLC | Increased | 14.5M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 11.9M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 10.9M | May 13, 2026 |
| FMR LLC | Increased | 10.6M | May 15, 2026 |
| FMR LLC | Reduced | 10.2M | Feb 17, 2026 |
| REDMILE GROUP, LLC | Increased | 10.1M | Feb 17, 2026 |
| BVF INC/IL | Increased | 9.1M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 9.0M | Feb 12, 2026 |
| BVF INC/IL | Reduced | 8.7M | May 15, 2026 |
| VANGUARD GROUP INC | Increased | 7.8M | Jan 29, 2026 |
| STATE STREET CORP | Increased | 6.9M | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Increased | 5.5M | Feb 17, 2026 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Unchanged | 5.2M | Feb 17, 2026 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Reduced | 5.2M | May 15, 2026 |
| BELLEVUE GROUP AG | Unchanged | 5.2M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.